- NEWS FEATURE
Is a boost to height a boost to health? Dwarfism therapies spark controversy
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 620, 936-939 (2023)
doi: https://doi.org/10.1038/d41586-023-02647-w
References
Shiang, R. et al. Cell 78, 335–342 (1994).
Yasoda, A. et al. Nature Med. 10, 80–86 (2004).
Savarirayan, R. et al. Lancet 396, 684–692 (2020).
Savarirayan, R. et al. Genet Med. 23, 2443–2447 (2021).
How a controversial US drug policy could be harming cancer patients worldwide
‘It’s a vote for hope’: first gene therapy for muscular dystrophy nears approval, but will it work?
Should you edit your children’s genes?